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Abstract
The circadian clock is an endogenous timer in prokaryotes and mammals. Resting and
adjusting the internal clock can assist in pacing the daily routine. Growing evidence
indicates  that  the  circadian  clock  and  aging  process  are  closely  associated.  The
disruption of the circadian clock leads to accelerated aging and increased incidence of
various diseases. In particular, elderly people are more vulnerable and have a higher
risk of diseases than do young people. In this study, we reviewed studies on aging and
circadian rhythms over the last decade, with a focus on circadian clock gene regula‐
tion in aging and drug discovery for targeting the circadian clock in diseases.
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1. Introduction
Circadian rhythms affect almost all daily activity behavioral patterns, physiology, and gene
expression. Circadian rhythms indicate the appropriate time for various activities, such as
consuming food and mating, and gradually form the circadian clock [1]. The circadian clock is
an internal timekeeping system, which facilitates adaptation to the external world in anticipa‐
tion of daily environmental changes. A 24-h circadian rhythm pattern has been observed in
almost all cells [2]. Circadian clocks coordinate external day and night cycles with diverse
environmental and metabolic stimuli. However, a disrupted circadian clock causes various
diseases, such as insomnia, diabetes, cancer, and metabolic syndrome [3]. The ability of the brain
timing system and function of  circadian rhythm-regulating genes  decline  with age.  The
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disruption of circadian rhythms disrupts the coordination among body systems. Aging damages
body homeostasis and results in a subhealth status [4]. Consequently, the systems of elderly
people are more vulnerable than those of young people [5]. The disruption of circadian rhythms
adversely affects the aging process and increases the risk of diseases. A set of circadian clock
genes form negative feedback loops that can regulate transcription, with a 24-h circadian
oscillation  [4,  6].  The  circadian  function  significantly  affects  the  aging  process.  Chronic
destructions of the circadian function are associated with the occurrence of various age-
related diseases, such as cancer and premature aging. Therefore, studies are warranted to
determine how the circadian clock genes orchestrate interactions between the internal physi‐
ology and the aging progress.
In this study, we reviewed studies within the last decade on aging and circadian rhythms and
the mechanism underlying the maintenance of biological processes by the circadian clock, with
a focus on circadian clock gene regulation in aging and antiaging drug discovery.
2. Circadian clock
2.1. Structure of the circadian system
Living systems possess an exquisite internal biological clock, and the major function of which
is to regulate the daily sleep–wake cycle [7]. The circadian clock follows a rhythm of approx‐
imately 24 h and ensures accurate adaptation to external daily rhythms through a powerful
endogenous timing system [8]. The circadian clock also drives numerous molecular and
cellular processes by generating oscillations. Virtually, all body cells have an autonomous
circadian clock [9, 10], which is composed of a central clock existing in the suprachiasmatic
nucleus (SCN) neuron and peripheral clocks. Clock, Bmal1 (brain and muscle ARNT-like
protein-1), Pers, and Crys constitute a set of circadian oscillation genes in mammals [11].
2.1.1. Suprachiasmatic nucleus
The central circadian clock, located in the SCN of the anterior hypothalamus, is the primary
circadian pacemaker [12]. The SCN comprises a network of approximately 20,000 neurons.
Each neuron is considered to have an oscillator of the autonomous circadian clock. As the
neurons are joined and oscillated in a consistent manner [13], the SCN neuron can generate an
autonomous circadian clock similar to other cells [14, 15]. The SCN as the primary circadian
pacemaker regulates independent gene expressions through neuronal firing [16].
The retina captures optical signals and transmits signals to the SCN (Figure 1) [17]. SCN
neurons organize coupling mechanisms that ensure their synchronization even in darkness
[18]. SCN neurons change the gene expression levels by converting electrical information into
chemical information [16]. Neuronal firing frequency can synchronize the other cells of the
body with rhythmic changes [19]. The central clock is controlled by external signals; food and
light are the strongest signals affecting the clock (Figure 1). Once synchronized, the central
clock consequently mediates the synchronization of the peripheral clocks through signaling
[20].
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Moreover, lability and plasticity of the phase in the intrinsic period are two critical functions
of the central clock [21]. As the phase is labile, the length of the intrinsic period leads to different
phases [22]. The waveform of the SCN amplitude is mainly related to the light cycle. The
waveform is narrow with a high amplitude in short photoperiods, whereas it is broader with
a low amplitude in long photoperiods. The circadian waveform in SCN oscillation is strong
correlated with the SCN and behavioral rhythms [23].
2.1.2. Peripheral clocks
Peripheral and central clocks have been discovered in various tissues. One study reported the
ubiquity of peripheral clock and its mechanism in both SCN and other cells [24]. Another study
reported that cultured SCN cells maintained a firm rhythmic pattern through photoreception,
also expressed in many organs, such as the liver, lungs, and kidneys [25]. In addition, numer‐
ous mammalian peripheral tissues exhibit circadian oscillation; consequently, oscillations are
suppressed when the SCN is absent [9]. Thus, a delayed feedback loop originally associating
the same components is considered to be composed of the rhythm-generating molecular
circuitry, which is constructed by both SCN and peripheral cells [16]. Several pivotal physio‐
logical functions are influenced by light–dark oscillations in peripheral organs (Figure 1),
including the heart, liver, lung, kidney, and skeletal muscles [26].
Figure 1. Structure of the circadian system. The retina captures photic information and transmits signals to the SCN.
Food and light transmit signals to the peripheral clock.
Local peripheral oscillators can be synchronized by neuronal signals and stimulating hor‐
mones. The SCN sends signals to all body systems, coordinating the feeding–fasting cycles [27,
28]. Although the SCN functions as the master synchronizer of the entire system, food intake
can disrupt the control in peripheral clocks. A change in the feeding schedule alters the phase
in the central and peripheral clocks in the liver [29]. Moreover, light information is transmitted
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to the adrenal gland, liver, and pancreas by the SCN, which distributes a rhythmic signal to
all tissues of the peripheral organs [30]. The central neural and peripheral tissues maintain the
normal neurological and metabolic homeostasis in the sleep–wake cycle [31]. The endogenous
mechanism of oscillation in peripheral cells is a gene regulatory network to generate sustained
oscillations. A group of genes forms the core network of the mammalian circadian clock, which
can function even in the absence of external inputs in individual cells [32]. Numerous signaling
pathways participate in the phase entrainment of peripheral clocks and warrant additional
studies.
2.2. Circadian clock and diseases
The circadian clock regulates the sleep–wake cycle, metabolism, hormone secretion, and other
physiological processes. A recent study suggested that chronic circadian disruption is
deleterious to health and causes myocardial infarction, sudden cardiac death, and aortic
aneurysm rupture risk [33]. Circadian dysregulation has extensive consequences not only on
glucose control but also on inflammation. REV–ERBα and retinoid-related orphan receptors
(RORs), which are downstream proteins of the signaling pathway, can affect adipogenesis and
thrombosis through circadian clock regulation. This study indicates that metabolic and
circadian pathways, which involve the nuclear receptor superfamily, are associated to the
central node [34].
Circadian rhythm and sleep disorders lead to an increased incidence of metabolic syndrome
[35]. Chronic sleep curtailment may affect the increase in the prevalence of diabetes and
obesity. The effect may change glucose metabolism by reducing energy consumption [36].
Hypothalamic–pituitary–thyroid axis rhythms are endocrine rhythms and are accurately
governed by the circadian system [37]. Evidence suggests that a seasonal change in thyroid
hormone availability in the hypothalamus, and pituitary gland is a crucial element [38]. Sex-
differentiated circadian timing systems exist in the hypothalamic–pituitary–gonadal (HPG)
axis, the hypothalamic–adrenal–pituitary (HPA) axis, and sleep-arousal systems [39]. When
various stressors appear, the HPA axis adjusts the circadian rhythms of the peripheral clocks
through the glucocorticoid receptor [40]. In addition, the female HPG axis is regulated by a
molecular clock in gonadotropin secretion because it relates to the timing of gonadotropin
secretion in ovulation and parturition [41]. The circadian timing system and estradiol sensitive
neural circuits driving the HPG axis functioning include gonadotropin-releasing hormone
secretion and preovulatory luteinizing hormone [42].
Moreover, a strong association exists between the circadian clock and hormone secretion. The
human placenta synthesizes the melatonin-regulating circadian system of many tissues, and
the unusual secretion adversely affects fetal and maternal health [43]. The circadian system,
which is composed of a family of clock genes, also regulates hormonal production and activity
[44]. Maternal melatonin is a circadian signal for oscillating the fetal SCN clock. However,
maternal melatonin probably cannot control the adrenal gland [45]; therefore, the circadian
clock system affects the fetus during embryonic development.
Adequate sleep is crucial for maintaining the function of circadian rhythms. The lack of sleep
disrupts circadian rhythms. Impaired endocrine and physiological circadian rhythms affect
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the quantity of immune cells [46]. Circadian oscillations can mediate cognitive performance
through sleep. However, it cannot work correctly in case of the environmental disturbance of
the clock, including shift work and schedules [47]. Circadian systems are disrupted through
inadequate melatonin secretion, and the altered clock gene expression can cause human
metabolic syndrome and cardiovascular diseases [35].
3. Circadian clock gene regulation in aging
Circadian oscillations regulate transcription by using a set of genes, thus establishing an
autoregulatory feedback loop. A study reported that circadian gene expression is widespread
through the body [19]. Animal studies have revealed that a disrupted circadian clock function
accelerated the development of aging phenotypes. The temporal precision of circadian system
is lost with advancing age. Growing evidence indicates that aging is affected by circadian
clocks. Circadian clocks can change gene expression, physiological functions, and daily cycles.
The circadian system leads to various age-related pathologies and exhibits a weak precision
with advancing age. The aged SCN shows changes in the expression of vasoactive intestinal
polypeptide [48]. Circadian rhythms of the electrical activity are decreased [49]. When a young
SCN is transplanted into aged animals, the behavioral rhythms functioning in locomotion is
improved [50]. These studies indicate that the SCN is crucial to improve the age-related
circadian system, which may be deteriorated in aged individuals.
Figure 2. Circadian clock gene regulation in aging.
Bmal1 and clock activate the expression of period (Per), cryptochrome (Cry), RORα, and REV–
ERBα. The negative elements of the clock PER and CRY proteins, which are associated with
Clock–Bmal1 at E-box sites, enter the nucleus. REV–ERBα competes with each other for their
binding DNA in the Bmal1 promoter, and the expression of Bmal1 is repressed.
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3.1. Effects of Bmal1 genes on the aging process
Bmal1 belongs to the family of the basic helix–loop–helix (bHLH)–PAS domain containing
transcription factors [51]. Bmal1 is a transcriptional factor and major component of the
circadian clock; it plays a critical role in accelerating aging and the development of age-related
pathologies. Bmal1 as the core clock gene regulates the expression of other circadian clock
genes, which affects the physiological circadian rhythm [52]. Bmal1 deficiency has been shown
to significantly shorten lifespan and accelerate senescence. Bmal1-/- mice have a shorter lifespan
and exhibit cataracts, organ shrinkage, and other symptoms of premature aging [53].
Bmal1 may be directly associated with premature aging and reduced lifespan. Recent studies
have reported a significantly weakened function of circadian rhythms in aged animals. The
disturbances in circadian rhythms may cause thrombosis, a critical result of age-related
cardiovascular diseases. Genetic ablation of the gene Bmal1 gene in mice significantly elevates
the circulating von Willebrand factor, fibrinogen, and PAI-1 [54]. Bmal1 regulates BDH1 and
PIK3R1; thus, Bmal1 affects metabolism, cell signaling, and the contractile function of the heart.
Bmal1 predicts impairments in ketone body metabolism and depressing glucose utilization in
the hearts of cardiomyocyte-specific Bmal1-knockout mice [55].
Bmal1 is crucial for regulating oxidative stress. Oxidative stress maintains reactive oxygen
species (ROS) homeostasis and senescence through the hypoxia-inducible factor-mediated
pathway. Bmal1-/- cells do not induce replicative senescence but rather stress-induced senes‐
cence. Stress-induced senescence causes cell and organ aging [56]. A recent study revealed a
significantly decreased rhythmic function in aged animals. The study reported that the activity
of the mammalian target of rapamycin complex 1 pathway is controlled by the circadian clock
through Bmal1-dependent mechanisms. This regulation evidenced an association between
aging and metabolism [57]. Bmal1 in the heart also determines the pathological consequences
of the chronic disruption of the circadian clock. Bmal1-/- mice develop dilated cardiomyopathy
with aging and decreased cardiac performance with changes in titin [58]. In addition, Bmal1
controls the blood coagulation pathway by changing platelet numbers and altering the
vascular function. This control results from arterial and venous thrombogenicity by attenuat‐
ing nitric oxide and anticoagulant factor synthesis [59].
3.2. Effects of Clock on the aging process
Clock is a circadian clock protein similar to Bmal1 and is a transcription factor of the circadian
system. Bmal1 and Clock have different functions in modulating the biological function. The
deficiency of Clock does not induce any significant age-related changes in organs and tissues;
however, they are affected in Bmal1-/- mice [60]. The results of Clock and Bmal1 deficiency in
physiology are different. Clock encodes a novel bHLH–PAS domain protein of transcription
factors [61, 62]. Clock is a unique gene with various features, including DNA binding, protein
dimerization, and domain activation [62]. Clock is widely recognized to have circadian
functions. The deficiency of the Clock protein significantly affects longevity. The aging of
Clock-deficient mice results in a higher rate of pathologies, cataracts, and dermatitis than that
of wild-type mice [60].
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When Clock is a mutant gene, the pattern of circadian gene expression loses circadian behavior
and is disrupted [61, 62]. While Clock in mice is knocked out, the robust circadian rhythms in
spontaneous activity are still expressed [63]. Bmal1 forms a heterodimer as the transcription‐
ally active complex to drive circadian rhythmicity in Clock-deficient animals [64]. In addition,
neuronal PAS domain protein 2 functionally replaces the Clock activity in Clock-deficient mice
[65]. Age-related circadian changes are caused by both wild-type and heterozygous Clock
mutants [66]. Clock–Bmal1 complex activate the transcription of other genes with E-box
elements in their promoters [67]. The dimers translocate to the nucleus and obstruct the Clock–
Bmal1 complex, thereby hindering the additional transcription of the other genes [68] and
ultimately leading Clock and Bmal1 to increase Per transcription and restart the cycle [69].
Clock, as the core component of circadian transcription, operates in complex with another
protein. Clock deficiency was shown to cause age-related cataracts [60]. Clock-deficient mice
lose body weight, relative organ weight, or ectopic calcification during aging. These mice
maintain behavioral rhythms, indicating that peripheral circadian oscillators require Clock
[70].
3.3. Effects of the Clock–Bmal1 complex on the aging process
In animals, a transcription–translation loop that revolves around the transcription factors
Clock and Bmal1 forms circadian oscillators. The core positive element of the clock is Clock–
Bmal1, which is the heterodimeric transcription factor output of circadian locomotor cycles
[71]. The negative elements of the clock PER and CRY proteins, associated with Clock–Bmal1
at E-box sites, enter the nucleus [64, 72] (Figure 2). The transcriptional activity of Clock–Bmal1
is suppressed by recruiting the SIN3–histone deacetylase (HDAC) complex and preventing
transcriptional termination [72, 73]. Histone acetyltransferases (HATs) and HDACs generate
rhythms in histone acetylation and the circadian rhythms [74]. Mixed-lineage leukemia
protein-1, a H3K4 methyltransferase, has a nonredundant role in the circadian oscillator [75].
The Jumonji C domain-containing H3K4me3 demethylase family and AT-rich interaction
domain-containing histone lysine demethylase 1a form a Clock–Bmal1 complex; the complex
is then recruited to the Per2 promotor, simultaneously enhancing transcription by Clock–
Bmal1 [76]. The transcription factors Clock and Bmal1, which form heterodimers and bind to
an E-box enhancer element, regulate gene transcription [77, 78]. Bmal1 and Clock activate the
genes Per and Cry. Once a certain concentration of PER and CRY proteins accumulate, they
form BMAL1–CLOCK complex, consequently inhibiting gene transcription (Figure 2) [79, 80].
Clock–Bmal1 is not simply a passive consequence of negative feedback protein but rather
induces proactive regulation [81]. As the core component of molecular clock, the Clock–Bmal1
complex controls numerous clock genes [82]. This complex may activate as well as repress
transcription, and the switch depends on the interaction of Clock–Bmal1 with Cry [83]. The
Clock–Bmal1-dependent recruitment of HATs promotes the periodic disruption of Clock–
Bmal1 [84]. Clock–Bmal1 as a signaling molecule resets the clock through the Ca2+-dependent
protein kinase C pathway [85, 86]. The cAMP response element-binding protein activates the
Clock–Bmal1 complex that rapidly resets phase and mediates the acute transactivation of
Clock–Bmal1, consequently inducing immediate-early Per1 transcription [87]. Clock–Bmal1
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DNA binding promotes rhythmic chromatin opening and remodeling. It mediates the
rhythmic transcription factors binding to Clock–Bmal1 and the transcriptional output,
suggesting that Clock–Bmal1 drives rhythmic gene expression and biological functions [88].
3.4. Effects of PER and CRY on the aging process
The Per and Cry genes can combine with the E-box domain promoters using Clock and Bmal1,
thus driving the transcription of messenger RNA [79, 80]. Per and Cry genes play a negative
transcriptional feedback loop in mouse [89]. When PER and CRY proteins reach adequately
high levels, they form dimer feedback to the nucleus. The Clock–Bmal1 complex is then binded
to turn off transcription [4]. Regulatory kinases Case in Kinase I epsilon (CKIε) of rodents
phosphorylates PER and degrades it to feed back to the cell nucleus [90, 91]. CKIε masks the
mPER1 nuclear localization signal, and mPer2 causes mPer1–mPer2 heterodimer formation in
the cytoplasm. Phosphorylation-dependent cytoplasmic retention may be the reason for
CKIε regulating the mammalian circadian rhythm [91]. In aged animals, Per1 transcription is
induced by light and reduced with a significantly longer delay to resynchronization [92],
whereas in young animals, the disruption of the Per genes results in insensitivity to light [89,
93].
Advancing age reduces retinal sensitivity, which causes various age-related diseases. In
elderly people, homeostatic sleep is association with the circadian clock gene Per3 in coding
regions. The Per3 gene associates with a phase advance in the melatonin profile; therefore,
elderly people experience more nocturnal wakefulness [5]. In situ hybridization for Per2
mRNA revealed that the age-related decrease in the diurnal rhythm amplitude in the hippo‐
campus may aggravate cognitive deficits [94]. Pattern differences in clock gene expression can
be associated with a depressive state. Under abnormal light–dark conditions, Per1 and Per2
genes may result in a depressive state [95]. The expression of rPer1, rPer2, or rCry1 mRNA is
similar in both young and old SCN; however, when stimulated by light, aging reduces the
gene expression [89]. A decreased Per gene expression suggests an impaired clock regulatory
network and stress defense pathways may accelerate aging [96].
3.5. Effects of the SIRT1 gene on the aging process
Sirtuins belong to the silent information regulator (SIR)2 family of proteins [97, 98]. SIR2 and
its orthologs regulate senescence in yeast, worms, and flies [99–101]. SIR2 retards senescence
and extends the lifespan of diverse species through caloric restriction [101, 102]. Sirtuins are
nicotinamide adenine dinucleotide (NAD+)-dependent deacylases, which promote cell
survival by suppressing apoptosis or senescence [103]. Sirtuins play key roles in expediting
the resistance by increasing antioxidant pathways and facilitating DNA damage repair [104].
Seven mammalian sirtuins exist, and SIRT1 is one of the most crucial mammalian SIR2
orthologs [98]. SIRT1 is involved in cellular metabolism and circadian core clockwork machi‐
nery in biological systems [105]. The direct deacetylation activity and NAD+ salvage pathway
were found to correlate with SIRT1 in the circadian rhythm system [106]. In addition, SIRT1
regulates the Clock–Bmal1 complex, and deacetylates and degrades Per2 [79]. The SIRT1
activity contributes to disturbances in the acetylation of H3 and Bmal1 and transduces cellular
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metabolic signals [105]. Moreover, SIRT1 has multiple downstream targets, including p53,
Ku70, nuclear factor-kappaB, forkhead box O factors, peroxisome proliferator-activated
receptor (PPAR) gamma coactivator 1-alpha (PCG-1α), PPARγ [98].
The central pacemaker is activated by SIRT1 to maintain robust circadian, and its decaying
may accelerate aging [107]. SIRT1 can produce moderate changes in the intrinsic circadian
period and is associated with age-related decline in the central clock. Some studies have
reported a possible association between aging, sirtuins, and clock genes. SIRT1 activates the
transcription of Bmal1 through PGC-1α to increase the amplitude of expression of BMAL1 and
other proteins to control circadian rhythms in the SCN [108]. Recent studies have suggested
that caloric restriction is a nongenetic manipulation that extends the lifespan; it is beneficial
because SIRT1 has led to the search for sirtuin activators [109]. SIRT1 avoids mice getting diet-
induced obesity by deacetylating and activating PGC-1α in the skeletal muscles [110]. In
addition, the activity of the adipogenic nuclear receptor PPARγ is repressed by SIRT1
activation, thus reducing fat accumulation and adipocyte differentiation [98]. Moreover, SIRT1
mediates the lifespan extension through caloric restriction, affecting metabolism and lifespan
in humans.
3.6. Effects of the ROR gene on the aging process
RORs are considered a core clock machinery because they regulate the cyclic expression of
Bmal1 and Clock, thus providing an essential link between the positive and negative loops of
the circadian clock [111]. RORs can be classified into three types: RORα, RORβ, and RORγ.
RORα is the first member of the ROR subfamily and resembles the retinoic acid receptors and
RXRs [112]. Both RORα and RORβ are required for the maturation of photoreceptors in the
retina, and RORγ affects the development of several secondary lymphoid tissues [113].
RORα, an orphan nuclear receptor, plays a crucial role in integrating the circadian clock and
regulating the cardiovascular function. Four RORα isoforms exist in humans, namely RORα1–
4, whereas only two isoforms α1 and α4 are present in mouse [114]. These isoforms participate
in the different physiological processes and exhibit a distinct pattern of tissue-specific expres‐
sion. For example, the expression of RORα1 and RORα4 was significantly higher in mouse
cerebellum than in other tissues, whereas RORα4 is predominantly expressed in liver tissues
[115]. RORα and REV–ERBα compete for the binding of their shared DNA-binding elements
in the Bmal1 promoter (Figure 2) [116, 117]. RORα displays rhythmic expression patterns
during the circadian cycle in some tissues. RORα expression shows a weak circadian oscillation
in the liver, kidneys, retina, and lungs [114, 118, 119]. Moreover, RORα promotes Bmal1
transcription [116] through two RORα autonomous response elements [118]. RORα1 enhances
the circadian amplitude of Bmal1 mRNA expression and regulates the downstream clock genes
after serum shock [118]. In addition, the reduced expression of RORα is closely associated with
aging in genetic hypertensive rats [120]. The enhancement of the RORα expression was shown
to antiaging in human endothelial cells by facilitating Bmal1 transcription, [121]. The defi‐
ciency of RORα causes cerebellar hypoplasia and affects Purkinje cell survival and differen‐
tiation in aging [122]. RORα has been shown to restraint age-related degenerative, including
muscular atrophy, immune deficiencies, osteoporosis, atherosclerosis, and inflammation [123,
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124]. RORα plays a neuroprotective role during development and provides protection against
this injury [124].
3.7. Effects of the REV–ERBα gene on the aging process
REV–ERB nuclear receptors are considered to be essential core clock components and serve as
pivotal regulators of rhythmic metabolism [125]. REV–ERB has α and β isoforms, which
coexpression in adipose tissues and the liver and brain [126, 127]. REV–ERBα, an orphan
nuclear receptor, negatively regulates the activity of the Clock–Bmal1 complex. Its transcrip‐
tion is controlled through Per and Cry transcription [128]. REV–ERBα competes with activators
of the ROR family of nuclear receptors for binding to specific ROR-responsive elements to
ensure the rhythmic transcription of Bmal1 and Clock [118, 129]. The development of metabolic
disorders indicates disrupted circadian rhythms [111]. REV–ERBA is associated with circadian
rhythms and metabolism and is pivotal in regulating the core mammalian molecular clock
(Figure 2). Furthermore, REV–ERBα controls the transcription of metabolic pathways while
serving as a crucial output regulator.
Age is the essential risk factor for metabolic syndrome. REV–ERBα connects the core clock and
numerous physiological processes. The deficiency of REV–ERBα results in asynchronous
circadian rhythms, with a tendency for diet-induced obesity, impaired glucose, and lipid
utilization leading to an increased risk of diabetes [130]. Evidence suggests that REV–ERB has
opened new avenues for treating metabolic syndrome by affecting the circadian rhythm and
metabolism [111]: for example, targeting REV–ERBα as a critical component of the peripheral
clock to treat bipolar disorder by affecting glycogen synthase kinase 3 [131]. REV–ERB agonists
can reduce dyslipidemia, hyperglycemia syndromes, and obesity [130, 132].
4. Drug discovery
New biological targets are being developed for discovering novel drugs. People can identify
with aging, thus antiaging drugs constitute a lucrative market. Medical therapy contributes in
delaying the aging process in humans. Researchers focus not only on the compounds having
a validated target but also on herbs used as antiaging products in traditional medicine. Some
drugs used to treat chronic diseases can be examined; these diseases are associated with
senescence, such as cardiovascular diseases, type 2 diabetes mellitus, and cancer. Some studies
on the compounds have been conducted, whereas studies on herbs are necessary. Many lead
compounds and approved drugs are derived from herbs. In China, traditional Chinese
medicine (TCM) has been investigated in large-scale clinical trials, with extensive research on
aging concerns. With the development of longevity drugs, Chinese herbs have been demon‐
strated to retard aging, such as Polygonum multiflorum, Ginseng. Meanwhile, TCM is gradually
attracting worldwide attention.
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4.1. Compounds as antiaging drugs
4.1.1. Rapamycin
Rapamycin, used as an immunosuppressive drug, has been recently considered for antiaging
treatments. Rapamycin retards multiple aspects of aging, including extending the lifespan and
slowing aging in mice [133]. Rapamycin evidences an association between metabolism and
longevity by controlling the target of rapamycin kinases to regulate cell growth and prolifer‐
ation through mitogenic signals [134]. In addition, rapamycin extends mouse lifespan princi‐
pally by inhibiting many aspects of cancer development [135]. Rapamycin appears to retard
the effects of age on the liver, endometrium [133], and bone marrow [136]. Rapamycin was
shown to reduce the effects of aging in mice [137]; it can retard clinically relevant β-amyloid
and tau accumulation in aged CNS tissues [138].
4.1.2. Resveratrol
Resveratrol, a natural phenol, retards aging by selective SIRT1 activation. Resveratrol as an
established antioxidant has multiple beneficial activities and delays the onset of age-associated
diseases. Resveratrol can reduce the expression of SIRT1 by using an acetylated substrate and
NAD+ [109]. In yeast, resveratrol extends the lifespan by upregulating Sir2 or increasing DNA
stability [99]. Resveratrol has antioxidant, antiaging, and antiangiogenic properties. Further‐
more, resveratrol plays a dual role on the vasculature; it maintains vascular fitness through its
anti-inflammatory and anticoagulant activities, whereas it inhibits angiogenesis to suppress
tumor growth [139].
4.2. Herbs as antiaging drugs
4.2.1. Polygonum multiflorumygonum multiflorum
Polygonum multiflorum, a crucial TCM, is extensively used for health maintenance and disease
treatment, particularly as an antiaging drug in China. An active component extracted from the
roots of P. multiflorum Thunb is called 2,3,5,4'-tetrahydroxystilbene-2-O-β-d-glucoside (THSG).
THSG, the major bioactive compound of P. multiflorum, has antioxidant [140], anti-inflamma‐
tory [141], and endothelial-protective activities [142]. Our previous study revealed that THSG
prevents vascular senescence by increasing eNOS expression and SIRT1 activity and reducing
the acetylation of p53 at the K373 site [143]. In another study, we indicated that THSG extends
the lifespan by promoting the expression of the longevity gene Klotho [144]. The antioxidant
capacity of THSG is similar to resveratrol or even stronger. Moreover, THSG possesses a potent
antioxidant capacity and extends the lifetime of the nematode Caenorhabditis elegans [145].
THSG is a potent antiaging drug and has potential as a pharmaceutical antiaging drug.
4.2.2. Ginseng
Ginseng is a highly valued herb in Asia and is recorded in Chinese Pharmacopoeia. The major
active components of ginseng are ginsenosides. The beneficial effects of ginseng have been
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investigated; ginseng and its constituents have antianemic, antiaging, antioxidant, antineo‐
plastic, and anti-stress activities. Rg1 and Rb1 improve the spatial learning ability by increasing
the hippocampal synaptic density [109, 110]. Ginseng could play a crucial role in enhancing
the defense system during the aging process. The mechanisms of ginsenosides warrant further
investigation.
5. Conclusion
Considerable progress has been made to unravel the association between the circadian clock
and aging. The role of circadian clocks in governing many other physiological systems has
been reported; however, sufficient data are lacking. The circadian clock represents a nearly
ubiquitous aspect of cellular regulation and molecular regulatory process, which exerts effects
on organismal behavior. The researches on circadian clock genes regulation in aging have
emerged recently, making the issue become attractive and outstanding.
The association between the circadian clock genes and aging might affect age-related diseases.
The circadian clock is altered in normal aging, resulting in a decreased amplitude of rhythms
in daily life, subsequently posing difficulties for humans to adjust to temporal changes. The
study has major implications in determining why circadian rhythms diminish during aging
and whether this decline could be reversed to tissue homeostasis and age-related diseases.
However, additional studies are required to comprehensively understand the circadian clock
effects on aging and obtain the target drug for extending the lifespan. Circadian genes must
be extensively studied, including their different signaling pathways that are unknown,
particularly the association between circadian genes and diseases. Focus on the effects of gene
expression, translation, and signaling alterations on the biological clock would increase our
knowledge regarding individualized treatment program and drug discovery.
Till date, studies have revealed several circadian clock genes that are crucial in regulating the
lifespan. The manipulation of circadian clock genes would largely benefit the study of aging.
This study not only explains circadian rhythm affects aging but also presents drugs for
determining the therapeutic potential of targeting the circadian clock in diseases.
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